Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Harbarth

Showing results (381-390 of 420) with videos related to

Pageof 42
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 6, 2023
A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in EuropeNasreen Hassoun-Kheir, Mariana Guedes, Marie-Therese Ngo Nsoga, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"Mark S Butler, Valeria Gigante, Hatim Sati, et al.
The Lancet. Infectious Diseases|August 12, 2023
COVID-19 pandemic: a catalyst for accelerating global action on patient safetyRebecca Grant, Daniel Benamouzig, Howard Catton, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2024
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsValeria Gigante, Richard A Alm, Daniela Melchiorri, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 21, 2023
Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysisRhys Kingston, Venanzio Vella, Koen B Pouwels, et al.
The Lancet. Infectious Diseases|July 23, 2022
Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitalsGaud Catho, Julien Sauser, Valentina Coray, et al.
Plos One|January 7, 2026
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from human carriage, the human-polluted environment, and food: Molecular epidemiology of two prospective cohorts in five European metropolitan areasTess D Verschuuren, Julia Guther, Maria Eugenia Riccio, et al.
The Lancet. Infectious Diseases|February 4, 2018
The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trialPleun Joppe van Duijn, Walter Verbrugghe, Philippe Germaine Jorens, et al.
The Lancet. Infectious Diseases|December 26, 2017
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisEvelina Tacconelli, Elena Carrara, Alessia Savoldi, et al.
Swiss Medical Weekly|December 9, 2025
Overview and evaluation of a nationwide hospital-based surveillance system for influenza and COVID-19 in Switzerland (CH-SUR): 2018-2023Jonathan A Sobel, Marie-Céline Zanella, Rebecca Grant, et al.
Pageof 42

Showing results (381-390 of 420) with videos related to

Sort By:
Pageof 42
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 6, 2023
A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in EuropeNasreen Hassoun-Kheir, Mariana Guedes, Marie-Therese Ngo Nsoga, et al.
Antimicrobial Agents and Chemotherapy|March 24, 2022
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant <i>Enterobacterales</i> Are Critical Priority Pathogens, Too!"Mark S Butler, Valeria Gigante, Hatim Sati, et al.
The Lancet. Infectious Diseases|August 12, 2023
COVID-19 pandemic: a catalyst for accelerating global action on patient safetyRebecca Grant, Daniel Benamouzig, Howard Catton, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2024
Multi-year analysis of the global preclinical antibacterial pipeline: trends and gapsValeria Gigante, Richard A Alm, Daniela Melchiorri, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 21, 2023
Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysisRhys Kingston, Venanzio Vella, Koen B Pouwels, et al.
The Lancet. Infectious Diseases|July 23, 2022
Impact of interactive computerised decision support for hospital antibiotic use (COMPASS): an open-label, cluster-randomised trial in three Swiss hospitalsGaud Catho, Julien Sauser, Valentina Coray, et al.
Plos One|January 7, 2026
Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae from human carriage, the human-polluted environment, and food: Molecular epidemiology of two prospective cohorts in five European metropolitan areasTess D Verschuuren, Julia Guther, Maria Eugenia Riccio, et al.
The Lancet. Infectious Diseases|February 4, 2018
The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trialPleun Joppe van Duijn, Walter Verbrugghe, Philippe Germaine Jorens, et al.
The Lancet. Infectious Diseases|December 26, 2017
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisEvelina Tacconelli, Elena Carrara, Alessia Savoldi, et al.
Swiss Medical Weekly|December 9, 2025
Overview and evaluation of a nationwide hospital-based surveillance system for influenza and COVID-19 in Switzerland (CH-SUR): 2018-2023Jonathan A Sobel, Marie-Céline Zanella, Rebecca Grant, et al.
Pageof 42